How big data can help retinal medicine

Useful conclusions have already been drawn from analyses of big data

How big data can help  retinal medicine
Leigh Spielberg
Leigh Spielberg
Published: Friday, September 6, 2019
[caption id="attachment_16395" align="alignleft" width="1024"] Adnan Tufail[/caption] “What is big data? Why am I interested in big data? And why should you be interested in it?” were the three big questions that Adnan Tufail, Moorfields Eye Hospital, London, United Kingdom sought to answer in his presentation. Entitled, “Big Data for Retina: Perspectives and Cautions,” Dr Tufail’s presentation was given to delegates at the 19th Annual EURETINA Congress in Paris yesterday morning. Dr Tufail’s interest in big data originated with the discrepancies that he had noticed between clinical trial results and real-world outcomes regarding anti-VEGF treatments. “Within two months, we had generated a database of more than 11,000 eyes,” he said. “Ironically, large data sets may help with precision medicine, meaning: what can an individual patient expect from a certain treatment?” said Dr Tufail. So why should ophthalmologists be interested? Because very useful conclusions have already been drawn from analyses of big data. Diabetic retinopathy progression can be predicted based on the baseline retinopathy and clinical features; a history of intravitreal injections is a significant predictor of posterior capsular rupture during cataract surgery; and software currently exists that can accurately distinguish age-related macular degeneration from normal eyes based on OCT. Big data is coming.
Tags: anti-VEGF, big data, diabetic retinopathy, intravitreal injections
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...